Hypoxia-Associated Marker CA IX Does Not Predict the Response of Locally Advanced Rectal Cancers to Neoadjuvant Chemoradiotherapy
| Autor: | Wolfgang Mueller-Klieser, Peter Vaupel, Marc Dimitrow, Arnulf Mayer, Heinz Schmidberger, Maren Ebert, Katja Oberholzer, Andreas Kreft |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
Tumor hypoxia medicine.diagnostic_test Colorectal cancer business.industry medicine.medical_treatment Hypoxia (medical) medicine.disease Radiation therapy 03 medical and health sciences 030104 developmental biology 0302 clinical medicine 030220 oncology & carcinogenesis Biopsy Cancer research medicine Immunohistochemistry medicine.symptom business Chemoradiotherapy Neoadjuvant therapy |
| Zdroj: | Advances in Experimental Medicine and Biology ISBN: 9781493930227 |
| Popis: | Hypoxia-associated proteome changes have been shown to be associated with resistance to chemo- and radiotherapy. Our study evaluated the role of the hypoxia-inducible (HIF)-1 target gene carbonic anhydrase (CA) IX in the prediction of the response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer (stages II and III). A total of 29 pretreatment biopsy specimens were stained for CA IX by immunohistochemistry, converted to digital images and evaluated in a quantitative fashion using image analysis software. Contrary to our expectations, a trend towards a correlation between better tumor regression (>50 %) and higher expression of CA IX (p = 0.056) was found. CA IX was also present more frequently in pathological tumor stage T1 (pT1) tumors (p = 0.048). Conversely, no association with lymph node metastasis was identified. In conclusion, as a single marker, CA IX expression is not able to identify a hypoxia-related treatment resistant phenotype in rectal cancer. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|